title: VEGF isoforms as outcome biomarker for anti-angiogenic therapy in recurrent glioblastoma.
authors: From the Institutes of Neurosurgery (Q.G.D., G.C., R.P.) and Pathology (M.M., T.C., L.M.L.), Università Cattolica del Sacro Cuore; and Istituto Superiore di Sanità (L.R.-V.), Rome, Italy.
authors: Quintino Giorgio
authors: QG
authors: D'Alessandris
authors: From the Institutes of Neurosurgery (Q.G.D., G.C., R.P.) and Pathology (M.M., T.C., L.M.L.), Università Cattolica del Sacro Cuore; and Istituto Superiore di Sanità (L.R.-V.), Rome, Italy.
authors: Maurizio
authors: M
authors: Martini
authors: From the Institutes of Neurosurgery (Q.G.D., G.C., R.P.) and Pathology (M.M., T.C., L.M.L.), Università Cattolica del Sacro Cuore; and Istituto Superiore di Sanità (L.R.-V.), Rome, Italy.
authors: Tonia
authors: T
authors: Cenci
authors: From the Institutes of Neurosurgery (Q.G.D., G.C., R.P.) and Pathology (M.M., T.C., L.M.L.), Università Cattolica del Sacro Cuore; and Istituto Superiore di Sanità (L.R.-V.), Rome, Italy.
authors: Gabriele
authors: G
authors: Capo
authors: From the Institutes of Neurosurgery (Q.G.D., G.C., R.P.) and Pathology (M.M., T.C., L.M.L.), Università Cattolica del Sacro Cuore; and Istituto Superiore di Sanità (L.R.-V.), Rome, Italy.
authors: Lucia
authors: L
authors: Ricci-Vitiani
authors: From the Institutes of Neurosurgery (Q.G.D., G.C., R.P.) and Pathology (M.M., T.C., L.M.L.), Università Cattolica del Sacro Cuore; and Istituto Superiore di Sanità (L.R.-V.), Rome, Italy.
authors: Luigi Maria
authors: LM
authors: Larocca
authors: From the Institutes of Neurosurgery (Q.G.D., G.C., R.P.) and Pathology (M.M., T.C., L.M.L.), Università Cattolica del Sacro Cuore; and Istituto Superiore di Sanità (L.R.-V.), Rome, Italy. pallini@rm.unicatt.it.
authors: Roberto
authors: R
authors: Pallini
mesh_terms: D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D014408:Biomarkers, Tumor / Q000235:genetics*; D001932:Brain Neoplasms / Q000188:drug therapy*; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011379:Prognosis; D020033:Protein Isoforms / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor; D020033:Protein Isoforms; D012333:RNA, Messenger; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab